Taken together, these results suggest that PI3Kβ/δ inhibition interferes with the growth of several DLBCL cell lines characterized by constitutive PI3K/AKT signaling independent of their molecular subtype. Here, PIK3CB is linked to diffuse large B-cell lymphoma.